Passage Bio reports positive Phase 1/2 trial results for PBFT02 in frontotemporal dementia, with planned protocol amendments for safety optimization. Passage Bio, Inc. announced positive results from ...
Hosted on MSN
Why Do Some People Get Dementia In Their 40s?
SAN FRANCISCO — Frontotemporal dementia (FTD) typically strikes adults in their 40s to 60s, often when they’re at the peak of their careers and family responsibilities. Unlike Alzheimer’s disease, ...
LONDON--(BUSINESS WIRE)--AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results